Delray Medical Center Advances its Endovascular Program as the First Hospital in Florida to Acquire the AI-Powered Viz Vascular Suite

As a leader in vascular care, Delray Medical Center is the first hospital in Florida to acquire the Viz Vascular Suite.  This is a comprehensive software its vascular care team can use to detect disease, optimize workflow, and coordinate care.

The Viz Vascular Suite uses artificial intelligence (AI) to automatically detect suspected pulmonary embolism, right/left ventricle dilation, aortic dissection, and abdominal aortic aneurysm to facilitate informed and efficient treatment decisions.

“Being able to identify a patient with a serious vascular condition, such as an abdominal aortic aneurysm, early – before they have an emergency, is a game changer and literally a lifesaver,” said Dr. Joseph Ricotta, professor of surgery and program director of the vascular surgery fellowship at Florida Atlantic University College of Medicine, and national medical director of vascular surgery and endovascular therapy at Tenet Healthcare. “For example, there are roughly 1.5 million abdominal aortic aneurysms in the US per year; however, only 10 percent get diagnosed and treated. We don’t often find out about them until it’s too late and, even then, there’s only a 25 percent chance of living through a ruptured aortic aneurysm. From my experience as an early adopter of this technology, the Viz Vascular Suite will help enhance screening and coordinate care across my vascular team.”

The Viz Vascular Suite is designed to automatically analyze imaging and data and, in turn, eliminate futile patient transfers between departments and decrease the time patients spend in the emergency department. Using the Viz.ai platform, care can be coordinated for any vascular pathology, and managed remotely within a hub and spoke network, which expedites diagnosis and treatment.  It also aids Delray Medical Center in activating its Pulmonary Embolism Response Team (PERT), which is a multidisciplinary team that rapidly assesses and provides treatment for patients with acute pulmonary embolism.

“We set out to build a solution where any patient with life-threatening, vascular diseases can benefit from AI-powered triage, fast mobile communication and synchronized care coordination,” said Gad Sakin, chief product officer at Viz.ai. “The Viz Vascular Suite is designed to bring the advantages of intelligent care coordination to even more patients and help clinical teams, like the one at Delray Medical Center, achieve better clinical outcomes.”

In addition to the latest acquisition of the Viz Vascular Suite, Delray Medical Center is utilizing the technology for an investigational study using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 system in the treatment of acute pulmonary embolism.  The purpose of this study is to evaluate the safety and effectiveness of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE in a prospective trial of patients with acute intermediate-risk pulmonary embolism.

Remaining on the forefront of new technology and treatments has been a hallmark of the vascular program at Delray Medical Center as it was the first in the country to perform endovascular robotic surgery, the first in Florida to perform trans-carotid revascularization (TCAR) for the treatment of carotid artery disease and stroke, the first in Florida to perform Venaseal TM for the treatment of venous disease, and the first in Palm Beach county to perform intravascular lithotripsy balloon angioplasty for peripheral vascular disease. Rounding out Delray Medical Center’s endovascular program are a Limb Preservation Program, a new Hybrid Endovascular OR Suite, the CorPath system for robotic-assisted vascular interventions, and the Artis pheno, which is a robotic C-arm angiography system for use in minimally invasive interventional procedures that improves flexibility in the OR by expanding patient access, reducing radiation and maintaining an uninterrupted sterile airflow with antimicrobial surfaces. Equipped with advanced, robotic surgical technology not available at any other hospital in Palm Beach County, the experienced team of physicians and surgeons at Delray Medical Center offer even more minimally invasive vascular interventional procedures to patients, including specialized procedures that are designed to spare tissue, repair damage and help maintain and restore function in limbs that would otherwise have to be amputated.

Other conditions treated include:

  • Aortic Aneurysm
  • Carotid Artery Disease
  • Deep Vein Thrombosis/Pulmonary Embolism
  • Diabetic Peripheral Neuropathy
  • Diabetic Ulcers/Wounds
  • Mesenteric and Renal Disease
  • Pelvic Congestion Syndrome and Thoracic Outlet Syndrome
  • Peripheral Vascular Disease/Peripheral Arterial Disease
  • Vascular Malformations
  • Venous Disease
  • Dialysis Access

For more information about the Endovascular Program at Delray Medical Center, log on to Endovascular Robotics Surgery Delray Beach, FL | Delray Medical Center (delraymedicalctr.com)

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."